DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported
In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt
Toxicity Testing Reorganization Announced; Rall To Head It Up
DCT Planning To Stop Use Monkeys In Preclinical Test
Grantees Seek $433.5 Million for construction
Leffall New ACS President, Gudberg, President-Elect
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Peter F. Garrett to people with cancer: Your story has power
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies









